Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

Before even hearing who the LymPro Partner is we will hear data at both Conferences in July and Revenue Guidance in the 2Q Conf. Call. That should pop us up into the .17 to .25 cent range before the partnership is even announced! Depending on the quality of the partnership it could take us to the .30 to .40 cent range.

I suspect Gerald will start his LymPro media blitz in the fall a month before we up list. That could pop us up even further.

Then comes the MANF orphan designation, taking us up further still.

I say we up list the beginning of November in the .40 to .60 cent range.